MLEC logo

Moolec Science SA (MLEC) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

Luxembourg

IPO:

02 March 2021

Indexes:

Not included

Description:

Moolec Science SA (MLEC) focuses on developing plant-based proteins through innovative biotechnology. The company aims to create sustainable food solutions by using molecular farming to produce high-quality ingredients, making it easier for people to enjoy healthier and more environmentally friendly food options.

Key Details

Price

$0.86

Annual Revenue

$5.63 M(+521.56% YoY)

Annual EPS

-$0.19(+87.33% YoY)

Annual ROE

-86.42%

Beta

-0.03

Events Calendar

Earnings

Next earnings date:

Jan 03, 2025

Recent quarterly earnings:

Oct 02, 2024

Recent annual earnings:

Oct 02, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

30 Jan '24 Maxim Group
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Moolec Has Received USDA Approval for the First Genetically Modified Pea in History
Moolec Has Received USDA Approval for the First Genetically Modified Pea in History
Moolec Has Received USDA Approval for the First Genetically Modified Pea in History
MLEC
accesswire.com16 October 2024

LUXEMBOURG / ACCESSWIRE / October 16, 2024 / Moolec Science SA (NASDAQ:MLEC) ("the Company"), a leader in Molecular Farming technology, announced today that the U.S. Department of Agriculture's ("USDA") Animal and Plant Health Inspection Service ("APHIS") has completed its Regulatory Status Review ("RSR") for the Company's genetically engineered ("GE") peas which produce iron through bovine meat proteins. This is the third regulatory clearance from USDA-APHIS achieved by Moolec in an 18-month window, alongside its genetically engineered safflower and soybean for GLASO™ and Piggy Sooy™ products, respectively.

Moolec Science Presents Fiscal Year 2024 Annual Business Update
Moolec Science Presents Fiscal Year 2024 Annual Business Update
Moolec Science Presents Fiscal Year 2024 Annual Business Update
MLEC
accesswire.com02 October 2024

LUXEMBOURG / ACCESSWIRE / October 2, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today reported its Business Update for the fourth quarter of Fiscal Year 2024 ended June 30, 2024. Moolec Science Logo The main highlights of Moolec's fourth quarter are as follows: GLASO™: The Company announced an offtake agreement with a major global CPG food and pet food company and an R&D collaboration agreement with Bunge.

Moolec Science (MLEC) Q4 2024 Earnings Call Transcript
Moolec Science (MLEC) Q4 2024 Earnings Call Transcript
Moolec Science (MLEC) Q4 2024 Earnings Call Transcript
MLEC
seekingalpha.com02 October 2024

Moolec Science SA (NASDAQ:MLEC ) Q4 2024 Earnings Conference Call October 2, 2024 8:30 AM ET Company Participants Gaston Paladini - Chief Executive Officer Jose Lopez Lecube - Chief Financial Officer Martin Salinas - Chief Technology Officer Amit Dhingra - Chief Science Officer Bill Zima - ICR Strategic Communications Conference Call Participants Scott Fortune - Roth Capital Operator Good morning and welcome to Moolec Science's fourth quarter and full fiscal year 2024 conference call. My name is Bill Zima of ICR Strategic Communications and Advisory.

Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call
Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call
Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call
MLEC
accesswire.com25 September 2024

LUXEMBOURG / ACCESSWIRE / September 25, 2024 / Moolec Science SA (NASDAQ:MLEC)("The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, announced today that it will release its Business Update for the Fourth Quarter and Full Fiscal Year 2024 on Wednesday, October 2, 2024, before the market opens. Moolec Sciences Logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra, will host a live Conference Call, followed by a question-and-answer session, on Wednesday, October 2, 2024 at 08:30am ET.

Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October
Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October
Moolec Confirms US Harvest and Promising Yields for Plant-Grown Products GLASO(TM) and Piggy Sooy(TM) in October
MLEC
accesswire.com05 September 2024

LUXEMBOURG / ACCESSWIRE / September 5, 2024 / Moolec Science SA (NASDAQ:MLEC) ("The Company", "Moolec"), a science-based food ingredient company, announced today the harvest confirmation of US campaigns for genetically engineered plant-grown products GLASO™ and Piggy Sooy™ during October 2024. GLASO™ and Piggy Sooy™ US Harvest Announcement GLASO™ (gamma-linolenic acid -GLA- in safflower oil) campaign located in Idaho consists of 600 planted acres of genetically modified safflower, mainly for commercial purposes.

Moolec Science to Host Second Quarter Fiscal Year 2024 Business Update Conference Call
Moolec Science to Host Second Quarter Fiscal Year 2024 Business Update Conference Call
Moolec Science to Host Second Quarter Fiscal Year 2024 Business Update Conference Call
MLEC
Accesswire06 March 2024

LUXEMBOURG / ACCESSWIRE / March 6, 2024 / Moolec Science SA (NASDAQ:MLEC) ("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the Second Quarter Fiscal Year 2024 on Wednesday, March 13, 2024, before the market opens. logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra will host a live Conference Call on Wednesday, March 13, 2024, at 08:30 am ET.

Down -18.03% in 4 Weeks, Here's Why You Should You Buy the Dip in Moolec Science SA (MLEC)
Down -18.03% in 4 Weeks, Here's Why You Should You Buy the Dip in Moolec Science SA (MLEC)
Down -18.03% in 4 Weeks, Here's Why You Should You Buy the Dip in Moolec Science SA (MLEC)
MLEC
Zacks Investment Research11 January 2024

Moolec Science SA (MLEC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Why Is Moolec Science (MLEC) Stock Up 40% Today?
Why Is Moolec Science (MLEC) Stock Up 40% Today?
Why Is Moolec Science (MLEC) Stock Up 40% Today?
MLEC
InvestorPlace11 January 2024

Moolec Science (NASDAQ: MLEC ) stock is getting a boost on Thursday despite a lack of news from the science-based food ingredient company. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is rising today.

Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call
Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call
Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call
MLEC
Accesswire07 December 2023

LUXEMBOURG / ACCESSWIRE / December 7, 2023 / Moolec Science SA (NASDAQ:MLEC)("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the First Quarter Fiscal Year 2024 on Thursday, December 14, 2023, before the market opens. MLEC Logo Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, and Chief Science Officer Amit Dhingra will host a live Conference Call, followed by a question-and-answer session, on Thursday, December 14, 2023, at 08:30am ET.

Moolec Science SA (MLEC) Q1 2023 Earnings Call Transcript
Moolec Science SA (MLEC) Q1 2023 Earnings Call Transcript
Moolec Science SA (MLEC) Q1 2023 Earnings Call Transcript
MLEC
Seeking Alpha31 May 2023

Moolec Science SA (NASDAQ:MLEC ) Q1 2023 Earnings Conference Call May 31, 2023 8:00 AM ET Company Participants Martín Taraciuk - Head, IR Gaston Paladini - Co-Founder, CEO & Director Amit Dhingra - Chief Science Officer Jose Lopez Lecube - CFO & Director Conference Call Participants Martín Taraciuk Good morning, and welcome to Moolec's conference call. My name is Martín Taraciuk, and I'm Moolec's Head of Investor Relations.

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the primary business of Moolec Science SA?
  • What is the ticker symbol for Moolec Science SA?
  • Does Moolec Science SA pay dividends?
  • What sector is Moolec Science SA in?
  • What industry is Moolec Science SA in?
  • What country is Moolec Science SA based in?
  • When did Moolec Science SA go public?
  • Is Moolec Science SA in the S&P 500?
  • Is Moolec Science SA in the NASDAQ 100?
  • Is Moolec Science SA in the Dow Jones?
  • When was Moolec Science SA's last earnings report?
  • When does Moolec Science SA report earnings?
  • Should I buy Moolec Science SA stock now?

What is the primary business of Moolec Science SA?

Moolec Science SA (MLEC) focuses on developing plant-based proteins through innovative biotechnology. The company aims to create sustainable food solutions by using molecular farming to produce high-quality ingredients, making it easier for people to enjoy healthier and more environmentally friendly food options.

What is the ticker symbol for Moolec Science SA?

The ticker symbol for Moolec Science SA is NASDAQ:MLEC

Does Moolec Science SA pay dividends?

No, Moolec Science SA does not pay dividends

What sector is Moolec Science SA in?

Moolec Science SA is in the Healthcare sector

What industry is Moolec Science SA in?

Moolec Science SA is in the Biotechnology industry

What country is Moolec Science SA based in?

Moolec Science SA is headquartered in Luxembourg

When did Moolec Science SA go public?

Moolec Science SA's initial public offering (IPO) was on 02 March 2021

Is Moolec Science SA in the S&P 500?

No, Moolec Science SA is not included in the S&P 500 index

Is Moolec Science SA in the NASDAQ 100?

No, Moolec Science SA is not included in the NASDAQ 100 index

Is Moolec Science SA in the Dow Jones?

No, Moolec Science SA is not included in the Dow Jones index

When was Moolec Science SA's last earnings report?

Moolec Science SA's most recent earnings report was on 2 October 2024

When does Moolec Science SA report earnings?

The next expected earnings date for Moolec Science SA is 3 January 2025

Should I buy Moolec Science SA stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions